Palbociclib plus letrozole combination after progression on second-line chemotherapy for women with er/pr-positive high-grade serous or endometrioid ovarian, fallopian tube or peritoneal cancer (lacog 1018)
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要